FDA Inspection 1112250 — SGS France
The FDA completed an inspection of SGS France on October 11, 2019 in Arcueil. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 11, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Arcueil (France)
Additional Details
Bioanalytical BA/BE